Table 1.
Patient- and disease-related characteristics
| Total population | Dietary intake in the past week | ||
|---|---|---|---|
| Normal | Less than normal | ||
| 516 (46%) | 615 (54%) | ||
| Age (years) | 65 ± 13 | 64 ± 13 | 66 ± 13 |
| Sex | |||
| Male | 626 (56%) | 305 (49%) | 321 (51%) |
| Female | 500 (44%) | 208 (42%) | 292 (58%) |
| Cancer stage | |||
| Carcinoma in situ/I | 249 (24%) | 133 (53%) | 116 (47%) |
| II | 180 (18%) | 92 (51%) | 88 (49%) |
| III | 177 (17%) | 76 (43%) | 101 (57%) |
| IV | 418 (41%) | 174 (42%) | 244 (58%) |
| Therapy situation | |||
| Diagnosis | 89 (8%) | 45 (51%) | 44 (49%) |
| Surgery | 346 (32%) | 161 (47%) | 185 (53%) |
| Radiotherapy | 36 (3%) | 16 (44%) | 20 (56%) |
| Systemic treatment | 305 (28%) | 160 (53%) | 145 (47%) |
| Treatment of complications | 76 (7%) | 29 (38%) | 47 (62%) |
| Palliative care | 96 (9%) | 28 (29%) | 68 (71%) |
| Multiple | 141 (13%) | 52 (37%) | 89 (63%) |
| Therapy goal | |||
| Curative | 684 (62%) | 330 (48%) | 354 (52%) |
| Palliative | 420 (38%) | 170 (41%) | 250 (59%) |
| Duration since hospital admission (days) | |||
| < 4 | 379 (34%) | 225 (59%) | 154 (41%) |
| 4–7 | 232 (21%) | 95 (41%) | 137 (59%) |
| 8–21 | 341 (30%) | 129 (38%) | 212 (62%) |
| > 22 | 169 (15%) | 66 (39%) | 103 (61%) |
| Comorbidity | |||
| None | 478 (42%) | 215 (45%) | 263 (55%) |
| One or more | 653 (58%) | 301 (46%) | 352 (54%) |
| Number of drugs per day | |||
| 0 | 132 (13%) | 75 (57%) | 57 (43%) |
| 1–2 | 227 (22%) | 112 (49%) | 115 (51%) |
| 3–5 | 322 (31%) | 150 (47%) | 172 (54%) |
| > 5 | 353 (34%) | 138 (39%) | 215 (61%) |
| Body mass index (kg/m2) | |||
| < 18.5 | 100 (9%) | 32 (32%) | 68 (68%) |
| 18.5–25 | 516 (48%) | 250 (48%) | 266 (52%) |
| 25–30 | 324 (30%) | 154 (48%) | 170 (52%) |
| 30–35 | 107 (10%) | 51 (48%) | 56 (52%) |
| > 35 | 31 (3%) | 16 (52%) | 15 (48%) |
| Unintentional weight loss in last 3 months | |||
| No | 387 (36%) | 238 (62%) | 149 (38%) |
| Yes | 683 (64%) | 251 (37%) | 432 (63%) |
| Self-reported performance score | |||
| 0 | 193 (18%) | 124 (64%) | 69 (36%) |
| 1 | 230 (22%) | 117 (51%) | 113 (49%) |
| 2 | 294 (28%) | 140 (48%) | 154 (53%) |
| 3 | 179 (17%) | 65 (36%) | 114 (64%) |
| 4 | 166 (16%) | 37 (22%) | 129 (78%) |
Data are presented as number (%) or mean ± standard deviation